40 related articles for article (PubMed ID: 30055301)
1. Rational development of topical climbazole formulations.
Paz-Alvarez M; Fung Tang C; Pudney PD; Lane ME
Int J Pharm; 2024 Mar; 653():123886. PubMed ID: 38331330
[TBL] [Abstract][Full Text] [Related]
2. Investigation of piroctone olamine delivery to the skin from single, binary and ternary solvent systems.
Tang CF; Pudney PDA; Lane ME
Int J Cosmet Sci; 2024 Jun; 46(3):357-367. PubMed ID: 38083900
[TBL] [Abstract][Full Text] [Related]
3. Effects of Sodium Salts of Fatty Acids and Their Derivatives on Skin Permeation of Cromolyn Sodium.
Akinbote OE; Verana G; Dandekar AA; Tijani AO; Mishra D; Puri A; Dinh S
AAPS PharmSciTech; 2023 Nov; 24(8):221. PubMed ID: 37919402
[TBL] [Abstract][Full Text] [Related]
4. Preparation, Characterization and Dermal Delivery of Methadone.
Kung CP; Sil BC; Hadgraft J; Lane ME; Patel B; McCulloch R
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31581625
[TBL] [Abstract][Full Text] [Related]
5. Glycols: The ubiquitous solvent for dermal formulations.
Yu HL; Goh CF
Eur J Pharm Biopharm; 2024 Mar; 196():114182. PubMed ID: 38224756
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the percutaneous absorption of progesterone in anhydrous permeation-enhancing base using the Franz skin finite dose model and mass spectrometry.
Banov D; Song G; Ip K; Seeley EH; Linehan ST; Bassani I; Ferron G; Bassani AS; Valdez BC
Arch Dermatol Res; 2024 May; 316(6):291. PubMed ID: 38814486
[TBL] [Abstract][Full Text] [Related]
7. Characterization of piroctone olamine for topical delivery to the skin.
Tang CF; Paz-Alvarez M; Pudney PDA; Lane ME
Int J Cosmet Sci; 2023 Jun; 45(3):345-353. PubMed ID: 36752028
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations.
Lapteva M; Faro Barros J; Kalia YN
Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399256
[TBL] [Abstract][Full Text] [Related]
9. 3D human foreskin model for testing topical formulations of sildenafil citrate.
Magnano GC; Quadri M; Palazzo E; Lotti R; Loschi F; Dall'Acqua S; Abrami M; Larese Filon F; Marconi A; Hasa D
Int J Pharm; 2024 Jan; 649():123612. PubMed ID: 37992980
[TBL] [Abstract][Full Text] [Related]
10. Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy.
Hostynek JJ; Dreher F; Maibach HI
Inflamm Res; 2010 Nov; 59(11):983-8. PubMed ID: 20703511
[TBL] [Abstract][Full Text] [Related]
11. Antifungal climbazole alters androgenic pathways in mammalian cells.
Ndiaye D; Perceau M; Lorcin M; Denis F; Gaté L
Toxicol In Vitro; 2024 May; 99():105854. PubMed ID: 38795739
[TBL] [Abstract][Full Text] [Related]
12. Modeling the percutaneous absorption of solvent-deposited solids over a wide dose range: II. Weak electrolytes.
Tonnis K; Jaworska J; Kasting GB
J Control Release; 2024 Jan; 365():435-447. PubMed ID: 37996054
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effect on skin permeation of polar and non-polar compounds.
Alsheddi L; Wanasathop A; Li SK
Int J Pharm; 2024 Jan; 649():123601. PubMed ID: 37956723
[TBL] [Abstract][Full Text] [Related]
14. Human urinary excretion kinetics of the antimycotic climbazole: Biomonitoring of two new metabolites after oral and dermal dosage.
Schönrath I; Schmidtkunz C; Ebert KE; Küpper K; Brüning T; Koch HM; Leng G
Toxicol Lett; 2024 Jun; ():. PubMed ID: 38936562
[TBL] [Abstract][Full Text] [Related]
15. Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems.
Venn-Watson SK; Butterworth CN
PLoS One; 2022; 17(5):e0268778. PubMed ID: 35617322
[TBL] [Abstract][Full Text] [Related]
16. In Vitro-In Vivo Correlation in Dermal Delivery: The Role of Excipients.
Patel A; Iliopoulos F; Caspers PJ; Puppels GJ; Lane ME
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924434
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Effect of Azole Antifungal Agents on the Stress Response and Nanomechanical Surface Properties of
Pacholak A; Burlaga N; Kaczorek E
Molecules; 2020 Jul; 25(15):. PubMed ID: 32717971
[TBL] [Abstract][Full Text] [Related]
18. Preparation, Characterisation, and Topical Delivery of Terbinafine.
Hossain ASMMA; Sil BC; Iliopoulos F; Lever R; Hadgraft J; Lane ME
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31652587
[TBL] [Abstract][Full Text] [Related]
19. Topical delivery of climbazole to mammalian skin.
Paz-Alvarez M; Pudney PDA; Hadgraft J; Lane ME
Int J Pharm; 2018 Oct; 549(1-2):317-324. PubMed ID: 30055301
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
